← Leaderboards
Virgil C Jordan
Northwestern University
$1,090,907
Attributed
$1,090,907
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$15,264,757 · 5
By mechanism
P50$14,173,850 · 2
T32$583,315 · 1
R01$287,092 · 1
R21$220,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University
Same institution · by research overlap
- Luisa Iruela-Arispe$34,850,245
- Olga Valery Volpert$5,550,870
- Yijun Zhu$2,421,892
- Hao F Zhang$15,987,786
- Edith Chen$11,576,668
Others in their field
Top investigators on “Breast Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$251,848,784
- Richard L Schilsky · University Of Chicago$110,812,897
- Walter John Curran · Thomas Jefferson University$96,881,565
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$87,504,493
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,613,341
Research focus
Breast NeoplasmsHormone Regulation /Control MechanismMcf7 CellDisease /Disorder ModelMicroarray TechnologyModel Design /DevelopmentDrug ResistanceCell CycleAthymic MouseEstrogen InhibitorTamoxifenThrombospondinsVascular Endothelial Growth FactorsAngiogenesisEstrogen ReceptorsCell Growth RegulationCell LineReceptor ExpressionApoptosisWomen'S HealthBlood ChemistryClinical ResearchCortisolDrug Administration Rate /Duration
Grant awards (17)
Pharmacogenetics of Sulfate Conjugation$287,092
R01 · FY2006 · GM · contact PI
SPORE IN BREAST CANCER$2,811,268
P50 · FY2004 · CA
SPORE IN BREAST CANCER$250,000
P50 · FY2004 · CA
SPORE IN BREAST CANCER$2,817,618
P50 · FY2003 · CA
SPORE IN BREAST CANCER$250,000
P50 · FY2003 · CA
Training Program in Signal Transduction and Cancer$197,980
T32 · FY2003 · CA
SPORE IN BREAST CANCER$2,735,690
P50 · FY2002 · CA
Training Program in Signal Transduction and Cancer$138,936
T32 · FY2002 · CA
EFFECT OF RALOXIFENE ON SALIVARY STEROIDS$110,250
R21 · FY2002 · CA
DRUG RESISTANCE TO ANTIESTROGENS$0
P50 · FY2002 · CA
SPORE IN BREAST CANCER$2,729,995
P50 · FY2001 · CA
TRAINING PROGRAM IN SIGNAL TRANSDUCTION AND CANCER$110,395
T32 · FY2001 · CA
EFFECT OF RALOXIFENE ON SALIVARY STEROIDS$110,250
R21 · FY2001 · CA
DRUG RESISTANCE TO ANTIESTROGENS$0
P50 · FY2001 · CA
SPORE IN BREAST CANCER$2,579,279
P50 · FY2000 · CA
TRAINING PROGRAM IN SIGNAL TRANSDUCTION AND CANCER$136,004
T32 · FY2000 · CA
DRUG RESISTANCE TO ANTIESTROGENS$0
P50 · FY2000 · CA